Form 4: Biote Corp. Director Stephen Mark Cone Reports Acquisition of Stock Options and Restricted Stock Units

Director Stephen Mark Cone reports acquisition of stock options and restricted stock units in Biote Corp.

Summary

• On May 21, 2024, Stephen Mark Cone, a director of Biote Corp., reported the acquisition of 65,258 stock options with an exercise price of $5.57, expiring on May 20, 2034.
• Cone also acquired 10,828 Deferred Settlement Restricted Stock Units (RSUs) which are the economic equivalent of one share of Issuer Class A Common Stock.
• The RSUs are fully vested upon grant but will be settled upon separation from service.
• The stock options will vest on the earlier of May 21, 2025, or the day prior to the date of the Issuer's 2025 Annual Meeting of Stockholders, contingent upon continuous service.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of insider transactions. The acquisition of stock options and RSUs could be seen as a positive sign of confidence, but it's also a routine part of executive compensation.

Positives

• The acquisition of stock options and RSUs by a director may indicate confidence in the company's future performance.

Future Outlook

The vesting of the stock options is contingent upon the Reporting Person's continuous service through the vesting date, suggesting an incentive for continued involvement with the company.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can be useful for investors assessing management's alignment with shareholder interests.

Comparison to Industry Standards

• Stock option grants and RSU awards are common forms of executive compensation in publicly traded companies, particularly in the biotechnology sector.
• The vesting schedules and exercise prices are typical and designed to align management's interests with long-term shareholder value.
• Comparable companies like Amgen, Gilead Sciences, and Regeneron Pharmaceuticals also utilize stock options and RSUs as part of their executive compensation packages.

Stakeholder Impact

• The acquisition of stock options and RSUs by a director can impact shareholder sentiment, potentially signaling confidence in the company's future performance.
• Employees may view this as a positive sign of leadership commitment.

Key Dates